Olanzapine Market Report – Research, Industry Analysis Reports and Market Demands

Global Olanzapine Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Olanzapine Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Olanzapine Consumption 2014-2024
- 2.1.2 Olanzapine Consumption CAGR by Region
2.2 Olanzapine Segment by Type
- 2.2.1 Patent Type
- 2.2.2 Generics Type
2.3 Olanzapine Consumption by Type
- 2.3.1 Global Olanzapine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Olanzapine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Olanzapine Sale Price by Type (2014-2019)
2.4 Olanzapine Segment by Application
- 2.4.1 Olanzapine Tablets
- 2.4.2 Other Medicine
2.5 Olanzapine Consumption by Application
- 2.5.1 Global Olanzapine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Olanzapine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Olanzapine Sale Price by Application (2014-2019)

3 Global Olanzapine by Players

3.1 Global Olanzapine Sales Market Share by Players
- 3.1.1 Global Olanzapine Sales by Players (2017-2019)
- 3.1.2 Global Olanzapine Sales Market Share by Players (2017-2019)
3.2 Global Olanzapine Revenue Market Share by Players
- 3.2.1 Global Olanzapine Revenue by Players (2017-2019)
- 3.2.2 Global Olanzapine Revenue Market Share by Players (2017-2019)
3.3 Global Olanzapine Sale Price by Players
3.4 Global Olanzapine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Olanzapine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Olanzapine Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Olanzapine by Regions

4.1 Olanzapine by Regions
- 4.1.1 Global Olanzapine Consumption by Regions
- 4.1.2 Global Olanzapine Value by Regions
4.2 Americas Olanzapine Consumption Growth
4.3 APAC Olanzapine Consumption Growth
4.4 Europe Olanzapine Consumption Growth
4.5 Middle East & Africa Olanzapine Consumption Growth

5 Americas

5.1 Americas Olanzapine Consumption by Countries
- 5.1.1 Americas Olanzapine Consumption by Countries (2014-2019)
- 5.1.2 Americas Olanzapine Value by Countries (2014-2019)
5.2 Americas Olanzapine Consumption by Type
5.3 Americas Olanzapine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Olanzapine Consumption by Countries
- 6.1.1 APAC Olanzapine Consumption by Countries (2014-2019)
- 6.1.2 APAC Olanzapine Value by Countries (2014-2019)
6.2 APAC Olanzapine Consumption by Type
6.3 APAC Olanzapine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Olanzapine by Countries
- 7.1.1 Europe Olanzapine Consumption by Countries (2014-2019)
- 7.1.2 Europe Olanzapine Value by Countries (2014-2019)
7.2 Europe Olanzapine Consumption by Type
7.3 Europe Olanzapine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Olanzapine by Countries
- 8.1.1 Middle East & Africa Olanzapine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Olanzapine Value by Countries (2014-2019)
8.2 Middle East & Africa Olanzapine Consumption by Type
8.3 Middle East & Africa Olanzapine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Olanzapine Distributors
10.3 Olanzapine Customer

11 Global Olanzapine Market Forecast

11.1 Global Olanzapine Consumption Forecast (2019-2024)
11.2 Global Olanzapine Forecast by Regions
- 11.2.1 Global Olanzapine Forecast by Regions (2019-2024)
- 11.2.2 Global Olanzapine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Olanzapine Forecast by Type
11.8 Global Olanzapine Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
In 2011, the Lilly’s patent protection expired that had undergone tremendous change of the olanzapine industry. More and more manufacturers had entered the industry leading to the fierce competition on the market. The value of sales of global olanzapine tablets dropped sharply in the past few years.
At present, the United States is the largest producer and consumer of the olanzapine. Almost all of the olanzapine are used for manufacturing the olanzapine tablets products, most of the olanzapine producers manufacture the olanzapine for self-use, only few for export. Lilly is the largest producer and dominants the high-end field. The rest of manufacturers manufactures the generic olanzapine products, facing the low-end market, like Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Mylan Pharmaceuticals, Par Pharmaceutical, Aurobindo Pharma, Torrent Pharmaceuticals, Jubilant Lifesciences, Sun Pharmaceutical, Sandoz, Hansoh Pharmaceutical, WATSON Pharmaceuticals and Zhejiang Langhua Pharmaceuticals etc. Canada India Israel and China play the important roles in the olanzapine market. But to the olanzapine tablets market, USA Japan and Europe are the most important consumers.

According to this study, over the next five years the Olanzapine market will register a 2.3% CAGR in terms of revenue, the global market size will reach US$ 210 million by 2024, from US$ 180 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Olanzapine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Olanzapine market by product type, application, key manufacturers and key regions and countries.

This study considers the Olanzapine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Patent Type
Generics Type
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Olanzapine Tablets
Other Medicine

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Olanzapine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Olanzapine market by identifying its various subsegments.
Focuses on the key global Olanzapine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Olanzapine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Olanzapine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.